May 27, 2026
Once confined to the realm of theoretical science fiction, cell and gene therapies (CGTs) have crossed decisively into clinical and commercial reality. In less than a decade, the world has witnessed landmark approvals, from the first CAR-T cell therapies for blood cancers to gene therapies restoring vision in patie...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper